Insights

Innovative Platform Navigo Proteins offers a cutting-edge protein engineering platform with unique scaffold proteins such as Affilin that are highly engineerable, stable, and economical. This enables tailored solutions for biopharmaceuticals and downstream processing, presenting opportunities to collaborate on custom affinity ligand development.

Strategic Partnerships Recent collaborations with prominent organizations like SCK CEN and VERAXA demonstrate Navigo's growing ecosystem, which enhances its product applications, especially in radiotheranostics and conjugation platforms. Sales teams can leverage these partnerships to identify clients in emerging biopharmaceutical and diagnostic markets.

Market Diversification Navigo's involvement in developing affinity resins for COVID-19 vaccine purification and targeting ligands for specific fusion proteins indicates a broad application range. This opens opportunities to target companies in vaccine manufacturing, biologics purification, and personalized medicine sectors.

Recent Innovations The company's ongoing development of Precision X ligands targeting contaminants and fusion proteins showcases its capability to offer advanced solutions for GMP manufacturing. Reaching out to biopharmaceutical firms seeking process improvements or novel purification methods could lead to mutually beneficial collaborations.

Growth Potential With a revenue range of one to ten million dollars and a dedicated team of up to 200 employees, Navigo Proteins presents a scalable opportunity for partners aiming to enhance their bioprocessing or drug development pipelines through innovative affinity ligand technologies and platform integrations.

Similar companies to Navigo Proteins GmbH

Navigo Proteins GmbH Tech Stack

Navigo Proteins GmbH uses 8 technology products and services including Calendly, HubSpot Cookie Policy Banner, Envoy, and more. Explore Navigo Proteins GmbH's tech stack below.

  • Calendly
    Appointment Scheduling
  • HubSpot Cookie Policy Banner
    Cookie Compliance
  • Envoy
    Load Balancers
  • Divi
    Page Builders
  • Bootstrap
    UI Frameworks
  • X-Content-Type-Options
    Web & Portal Technology
  • Apache
    Web Servers
  • easy pie chart
    Web Tools And Plugins

Media & News

Navigo Proteins GmbH's Email Address Formats

Navigo Proteins GmbH uses at least 1 format(s):
Navigo Proteins GmbH Email FormatsExamplePercentage
First.Last@navigo-proteins.comJohn.Doe@navigo-proteins.com
50%
First.Last@navigo-proteins.comJohn.Doe@navigo-proteins.com
50%

Frequently Asked Questions

What is Navigo Proteins GmbH's official website and social media links?

Minus sign iconPlus sign icon
Navigo Proteins GmbH's official website is navigo-proteins.com and has social profiles on LinkedIn.

What is Navigo Proteins GmbH's SIC code NAICS code?

Minus sign iconPlus sign icon
Navigo Proteins GmbH's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Navigo Proteins GmbH have currently?

Minus sign iconPlus sign icon
As of December 2025, Navigo Proteins GmbH has approximately 54 employees across 2 continents, including EuropeAsia. Key team members include Chief Development Officer (cdo): C. B.Chief Scientific Officer & Managing Director: U. H.Head Of Business Development: M. H.. Explore Navigo Proteins GmbH's employee directory with LeadIQ.

What industry does Navigo Proteins GmbH belong to?

Minus sign iconPlus sign icon
Navigo Proteins GmbH operates in the Biotechnology Research industry.

What technology does Navigo Proteins GmbH use?

Minus sign iconPlus sign icon
Navigo Proteins GmbH's tech stack includes CalendlyHubSpot Cookie Policy BannerEnvoyDiviBootstrapX-Content-Type-OptionsApacheeasy pie chart.

What is Navigo Proteins GmbH's email format?

Minus sign iconPlus sign icon
Navigo Proteins GmbH's email format typically follows the pattern of First.Last@navigo-proteins.com. Find more Navigo Proteins GmbH email formats with LeadIQ.

When was Navigo Proteins GmbH founded?

Minus sign iconPlus sign icon
Navigo Proteins GmbH was founded in 2017.

Navigo Proteins GmbH

Biotechnology ResearchSaxony-anhalt, Germany51-200 Employees

Navigo Proteins discovers and develops novel scaffold proteins-based affinity ligands for commercial biologics GMP purification or as biopharmaceutical drugs/binders. They are all small, stable, highly engineerable, selective, and economically, homogeneously producible.
In PRECISION CAPTURING a protein A-like scaffold serves for an antibody-like capture step even of non-Fc bearing molecules.
In PRECISION TARGETING human ubiquitin is the basis for highly selective Affilin® ligands as part of a broad range of biopharmaceutical drugs.
Navigo Proteins’ unique protein engineering expertise is the basis a world-wide unique, versatile scaffold proteins platform. Our robust, rapid and reliable high-throughput-based, robotics assisted platform designs, produces, analyzes and selects suitable affinity ligand proteins, optimized for their tasks in industrial downstream processing or as biopharmaceutical drugs.

PRECISION CAPTURING creates custom ligands against any biologic, Fc-independent, and enables antibody-like affinity downstream processes, with competitive binding capacities, caustic stabilities, usage-cycles, flow rates and commercially available off-the-shelf leaching assays. It is applicable for purifying any recombinant protein, mAb, virus, VLP, cell, etc. 
Navigo Proteins has established partnerships worldwide to convert its custom affinity ligands into ready-to-use, GMP-compliant affinity resins for commercial downstream processing.

Our PRECISION TARGETING platform creates tailored ligands which bind any desired biologic in biopharmaceutical or in diagnostic use, e.g. radiopharmaceuticals, Protein-drug-conjugates, CAR-T ligands or theranostics, in which the same Affilin® binder is employed in diagnosis, treatment and treatment-monitoring.

Navigo Proteins is about 70 heads strong, steadily growing and based in Halle, S/W of Berlin. We offer our expertise to interested pharma, biotech and life sciences companies.
https://www.navigo-proteins.com/imprint

Section iconCompany Overview

SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2017
Employees
51-200

Section iconFunding & Financials

  • $1M$10M

    Navigo Proteins GmbH's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    Navigo Proteins GmbH's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.